Using AI for Gene Therapy Design, Dyno Scoops Up $100 Million to Expand Platform

Since emerging from stealth mode in 2020 with multiple collaborations in place with big pharma companies, Dyno Therapeutics has been busy advancing its gene therapy platform. This morning, the company bolsters its research with $100 million raised in a Series A financing round.